Skip to main content

BIOS · BioSenic · Financials

0.0020 EUR -0.0002 (-9.09%) At close · May 26
Market Cap
1.31M EUR
Shares
652.86M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
3.07M +464.8%
FY2024 Revenue FY2020–FY2024
Net Income
-4.77M +83.4%
FY2024 Net Income FY2020–FY2024
Operating Margin
-169.71% +1126.8pp
FY2024 Operating Margin FY2020–FY2024
Operating Cash Flow
-2.22M +36%
FY2024 Operating Cash Flow FY2020–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2024 FY2023 FY2022 FY2021 FY2020
EUR 3.07M 543K 0 0 1M
EUR 2.31M 3.93M 1.03M 619K 15.42M
EUR 2.77M 3.65M 1.55M 570K 3.27M
EUR -5.21M -7.04M -2.32M -877K -15.02M
EUR 2.23M 5.95M 741K 107K 747K
EUR -6.71M -29.03M -3.05M -984K -15.75M
EUR 0 -7000 0 0 78K
EUR -4.77M -28.78M -2.04M -984K -11.94M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.